论文部分内容阅读
目的:讨论阿替普酶溶栓治疗急性ST段抬高型心肌梗死的疗效。方法:选取2015年6月至2016年8月,76例急性ST段抬高型心肌梗死患者进行研究,分为研究组和对照组,对照组在常规治疗的基础上,采用传统的溶栓治疗方式进行治疗,研究组采用阿替普酶治疗方式进行治疗。结果:研究组患者的有效率94.74%明显优于对照组的81.58%,同时研究组患者的不良反应发生情况明显低于对照组,(p<0.05)。结论:采用阿替普酶静脉溶栓治疗急性ST段抬高型心肌梗死的临床效果较为显著,可以有效的缓解患者临床症状,加速血栓的溶解。
Objective: To discuss the therapeutic effect of alteplase thrombolysis in acute ST-segment elevation myocardial infarction. Methods: From June 2015 to August 2016, 76 patients with acute ST-elevation myocardial infarction were selected and divided into study group and control group. On the basis of routine treatment, the control group received conventional thrombolytic therapy Way for treatment, the study group used alteplase treatment for treatment. Results: The effective rate of study group was 94.74%, which was significantly better than that of control group (81.58%). The incidence of adverse reactions in study group was significantly lower than that of control group (p <0.05). Conclusion: The clinical effect of intravenous infusion of alteplase for acute ST-segment elevation myocardial infarction is significant, which can effectively relieve the clinical symptoms and accelerate the dissolution of thrombus.